• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PRINGY JUVEDERM VOLBELLA XC 2 X 1ML 32G; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PRINGY JUVEDERM VOLBELLA XC 2 X 1ML 32G; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 96181
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Nodule (4551)
Date of Event 05/24/2025
Type of Reportable Event Serious Injury
Event or Problem Description
The healthcare professional reported that the patient was injected with 0.5 ml of juvéderm® volbella¿ xc in the vermilion lips.Two months later, patient was injected with 0.3 ml of juvéderm® volbella¿ xc in the lips.Two months later, patient was injected with 1 ml of juvéderm® voluma¿ xc in the cheeks.Two weeks later, patient developed 3 lumps inside bottom lip and 1 top right upper lip at cupid's bow with burning sensation and swellings.Patient felt run down without fever.The patient was treated with steroids and valtrex.Two months later, patient was treated with 3 rounds po steroids, valtrex, antihistamine, 0.2 ml of hylenex, and r/u lisinopril reaction as culprit of oral swelling.Symptoms resolved approximately 3 months after onset.This record is for the 1st injection of juvéderm® volbella¿ xc.
 
Additional Manufacturer Narrative
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLBELLA XC 2 X 1ML 32G
Common Device Name
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
PRINGY
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
8479366324
MDR Report Key23733377
Report Number3005113652-2025-01111
Device Sequence Number13402547
Product Code LMH
UDI-Device Identifier10888628043541
UDI-Public(01)10888628043541(10)1001411043(11)240228(17)260128
Combination Product (Y/N)Y
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
P110033
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 12/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/28/2026
Device Catalogue Number96181
Device Lot Number1001411043
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/26/2025
Initial Report FDA Received Date12/05/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/28/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age46 YR
Patient SexFemale
-
-